MAPT and Alzheimer disease: As expected from previous studies [4, 21] we found the highest levels of Aβ-PET and tau-PET signals in cortical brain regions of patients with typical and atypical AD, whereas patients with 4RTs showed low Aβ-PET levels and subcortical predominance of tau accumulation (Fig. 1B).